Sarepta Therapeutics Inc - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Representative image of a United States Navy unmanned surface vessel operating near a naval warship, illustrating the US Navy’s MASC programme cancellation and the launch of the $2.1 billion MUSV marketplace under the Golden Fleet strategy.

US Navy cancels MASC programme, launches $2.1bn MUSV marketplace as the Golden Fleet strategy moves from concept to procurement

No Kings protests return to New York City for third time as nationwide mobilisation targets Trump administration policies

Representative image of the BA.3.2 “Cicada” COVID variant under surveillance as the Centers for Disease Control and Prevention tracks detections across 25 United States states and the World Health Organization flags potential immune escape risk.

CDC tracks BA.3.2 Cicada COVID variant across 25 US states as WHO flags immune escape risk

A small imaging trial could reshape how brain metastases are detected and Radiopharm Theranostics is betting on it (ASX: RAD)

Read More

5 minute read

Pharma Industry News

Will Sarepta’s Elevidys succeed where others stalled? All eyes on EMBARK trial’s 3-year data drop

Find out how Sarepta’s 3-year Elevidys trial data could reshape investor sentiment, regulatory outlook, and Duchenne gene therapy strategy.

byPallavi Madhiraju

January 24, 2026

web analytics